Sands Capital Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,542
| Closed | -$180K | – | 78 |
|
|
2024
Q4 | $180K | Hold |
12,542
| – | – | ﹤0.01% | 71 |
|
|
2024
Q3 | $283K | Sell |
12,542
-2,322,359
| -99% | -$52.4M | ﹤0.01% | 67 |
|
|
2024
Q2 | $45.4M | Sell |
2,334,901
-1,048,240
| -31% | -$20.4M | 0.13% | 58 |
|
|
2024
Q1 | $127M | Sell |
3,383,141
-207,004
| -6% | -$7.77M | 0.36% | 45 |
|
|
2023
Q4 | $201M | Sell |
3,590,145
-395,325
| -10% | -$22.1M | 0.61% | 39 |
|
|
2023
Q3 | $164M | Sell |
3,985,470
-134,799
| -3% | -$5.56M | 0.56% | 41 |
|
|
2023
Q2 | $230M | Buy |
4,120,269
+382,501
| +10% | +$21.4M | 0.71% | 39 |
|
|
2023
Q1 | $209M | Buy |
3,737,768
+530,985
| +17% | +$29.6M | 0.69% | 39 |
|
|
2022
Q4 | $117M | Sell |
3,206,783
-184,394
| -5% | -$6.72M | 0.44% | 48 |
|
|
2022
Q3 | $96.6M | Sell |
3,391,177
-135,701
| -4% | -$3.86M | 0.36% | 50 |
|
|
2022
Q2 | $160M | Buy |
3,526,878
+325,484
| +10% | +$14.7M | 0.55% | 40 |
|
|
2022
Q1 | $244M | Buy |
3,201,394
+1,537,427
| +92% | +$117M | 0.56% | 40 |
|
|
2021
Q4 | $248M | Buy |
+1,663,967
| New | +$248M | 0.46% | 42 |
|